The available pharmacotherapy for the treatment of DM includes insulin and various oral hypoglycemic agents like sulfonylureas, metformin, α-glucosidase inhibitors (acarbose and troglitazone), and pioglitazone/rosiglitazone [31] (Table 1 and Table 2). This evidence concerns the gene INS and diabetes mellitus.